England

Please tell us where you live so that we can provide you with the most relevant information as you use this website.
If you are at a BFPO address please choose the country or region in which you would ordinarily be resident.
Accessibility statement
Qualification dates
StartEnd
03 Oct 2026Jun 2027
This module uncovers the translational research ‘pipeline’ underpinning the development of many medical interventions. You’ll cover the key aspects of this multidisciplinary process, including preclinical research, clinical trials and practice implementation. Beginning with the fundamentals of translational research, you’ll next examine three case studies featuring interventions applied in distinct contexts: ACL injury, Parkinson’s Disease and cancer. You’ll also use published scientific articles to develop your literature engagement and critical thinking skills. By the end of the module, you’ll have a thorough understanding of translational research practices and how they can be applied to develop therapeutic interventions for various health conditions.
Topic 1: Fundamentals of translational medicine
First, you’ll develop your core knowledge and understanding of translational research, a process often conceptualised as a multi-step ‘pipeline’. You’ll follow the journey of how basic scientific ideas translate into clinically effective treatments, focusing on crucial ethical, safety and regulatory considerations and the importance of detailed and standardised translational research plans, reports and outcomes. To illustrate key aspects, you’ll examine contemporary real-world examples.
Topic 2: Musculoskeletal medicine case study
In Topic 2, you’ll start by understanding the composition of the musculoskeletal system and the impact of MSK-associated conditions on individuals and society, focusing on the knee and ACL (anterior cruciate ligament) damage. You’ll then explore the structure and function of the knee, followed by knee biomechanics and the mechanisms of ACL injury. Finally, you’ll learn about the development and efficacy of surgical interventions for ACL repair, as well as research in preventative medicine intended to reduce the occurrence of these potentially devastating injuries.
Topic 3: Parkinson’s Disease case study
In the third topic, you’ll begin by considering the signs, symptoms and pathophysiology of Parkinson’s Disease, focusing on its impact on central nervous system signalling mediated by the neurotransmitter dopamine. Next, you’ll explore the developmental journeys of pharmacological- and device-based therapeutic interventions, including deep brain stimulation, before looking at ongoing research into biological-based approaches, including stem cell treatment. You’ll also consider integrating multiple treatment methods, including psychological, occupational and physical therapies, into a holistic management strategy.
Topic 4: Cancer case study
The final case study focuses on developing and optimising a monoclonal antibody treatment for cancer while considering side effects like cardiotoxicity. First, you’ll examine the therapy’s molecular target and the associated signalling cascade. Next, you’ll examine the therapeutic agent’s preclinical development, mechanistic characterisation, and initial clinical deployment. Finally, you’ll explore how modifications to the agent and treatment regimens enhance efficacy.
Topic 5: Unifying themes
The last topic brings together the key themes. You’ll reflect on the current state of the translational research process and the ‘pipeline’ concept, considering what the future may hold for translational medicine.
You must have passed or be studying the following:
Or two of the following:
You’ll be able to access the module website 2–3 weeks before the module starts, so you can learn to navigate the website and organise your study plan. A module primer, which contains basic concepts relevant to the module that you should understand, will also be provided. You can use this primer to refresh your knowledge before starting your studies and as a resource throughout the module.
You’ll get help and support from an assigned tutor throughout your module.
They’ll help by:
Online tutorials run throughout the module. While they’re not compulsory, we strongly encourage you to participate. Where possible, we’ll make recordings available.
Course work includes:
You’ll have access to a module website, which includes:
Additionally, the website includes:
The OU strives to make all aspects of study accessible to everyone, and this Accessibility Statement outlines what studying SK322 involves. You should use this information to inform your study preparations and any discussions with us about how we can meet your needs.
To find out more about what kind of support and adjustments might be available, contact us or visit our Disability support website.
Translational medicine (SK322) starts once a year – in October.
It will next start in October 2026.
We expect it to start for the last time in October 2032.
Back to previous page